These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 11837221)
1. New Food and Drug Administration-based oversight over genetic testing. Press RD Mol Diagn; 2001 Dec; 6(4):348-9. PubMed ID: 11837221 [No Abstract] [Full Text] [Related]
2. Protecting human research subjects: ten common problems. Puglisi T Health Law News; 2000 Jun; 13(3):8, 15. PubMed ID: 12542046 [No Abstract] [Full Text] [Related]
3. HHS ruling on Plan B introduces new risk for drugmakers. Willyard C Nat Med; 2012 Jan; 18(1):8. PubMed ID: 22227652 [No Abstract] [Full Text] [Related]
5. Leavitt: reforms will improve oversight and openness at FDA. FDA Consum; 2005; 39(3):37. PubMed ID: 16127819 [TBL] [Abstract][Full Text] [Related]
6. Panel recommends independence, more resources for FDA. Am J Hosp Pharm; 1991 Aug; 48(8):1632, 1639. PubMed ID: 1897535 [No Abstract] [Full Text] [Related]
7. Supplemental standards of ethical conduct and financial disclosure requirements for employees of the Department of Health and Human Services. Interim final rule with request for comments. Department of Health and Human Services (HHS) Fed Regist; 2005 Feb; 70(22):5543-65. PubMed ID: 15690579 [TBL] [Abstract][Full Text] [Related]
8. Health care, public health, and the food and agriculture critical infrastructures. Boddie WS; Kun L IEEE Eng Med Biol Mag; 2008; 27(6):54-8. PubMed ID: 19004696 [No Abstract] [Full Text] [Related]
10. Ethical considerations of new guidelines for emergency research. McCarthy CR Am J Respir Crit Care Med; 1996 Feb; 153(2):507-8. PubMed ID: 8564088 [No Abstract] [Full Text] [Related]
11. Messing with home brews. Nat Biotechnol; 2007 Mar; 25(3):262. PubMed ID: 17344864 [No Abstract] [Full Text] [Related]
12. A regulatory perspective on in vitro diagnostics. Gottlieb S; Woodcock J Nat Biotechnol; 2006 Aug; 24(8):927-9. PubMed ID: 16900132 [No Abstract] [Full Text] [Related]
13. Personal genetic tests facing scrutiny. Schmidt C J Natl Cancer Inst; 2008 Mar; 100(6):382-3, 386. PubMed ID: 18334700 [No Abstract] [Full Text] [Related]
14. DEA reschedules hydrocodone combination products as schedule II. J Mich Dent Assoc; 2014 Oct; 96(10):11. PubMed ID: 25647867 [No Abstract] [Full Text] [Related]
15. Hew review panel on new drug regulation. Dorsen N N Engl J Med; 1976 Dec; 295(24):1383-4. PubMed ID: 980092 [No Abstract] [Full Text] [Related]
16. Food and drug administration expanded access to treatment: implications for oncology patients. Freedman RS; Markman M Cancer; 2007 Jun; 109(11):2157-60. PubMed ID: 17450587 [No Abstract] [Full Text] [Related]
17. Reagan is leaving his mark on the Food and Drug Administration. Kosterlitz J Natl J (Wash); 1985 Jul; 17(27):1568-72. PubMed ID: 10271744 [No Abstract] [Full Text] [Related]
19. What's new in the regulation of health hazards. Clayton FW Proc Annu Meet U S Anim Health Assoc; 1978; (82):362-79. PubMed ID: 287102 [No Abstract] [Full Text] [Related]
20. The FDA approach to standardization and quality assurance of nucleic acid tests used to screen blood and plasma donations. Epstein JS; Hewlett IK Dev Biol (Basel); 2000; 102():223-7. PubMed ID: 10794110 [No Abstract] [Full Text] [Related] [Next] [New Search]